azomycin has been researched along with Hepatocellular Carcinoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, F; Li, Y; Ma, M; Meng, T; Shang, X; Shi, K; Tian, Y; Yuan, H | 1 |
| Chen, J; Li, X; Li, Y; Li, Z; Ma, P; Nai, J; Qu, H; Song, Z; Tang, X; Wang, Z; Xin, H; Zhang, J | 1 |
| Gnabre, JN; Hsu, MH; Huang, RC; Hwu, JR; Mold, DE; Pao, KC; Unlu, I; Wu, SC | 1 |
| Kumar, P; Narain, R; Quan, S; Wang, Y; Zhou, A | 1 |
| Brader, P; Carlin, S; Chun, YS; Fong, Y; Hricak, H; Ling, CC; Riedl, CC; Singh, P; Wen, B; Woo, Y; Zanzonico, PB | 1 |
| Natarajan, AT; Santos, SJ; Takahashi, CS | 1 |
6 other study(ies) available for azomycin and Hepatocellular Carcinoma
| Article | Year |
|---|---|
A Hypoxia-Sensitive Drug Delivery System Constructed by Nitroimidazole and its Application in the Treatment of Hepatocellular Carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Folic Acid; Humans; Hypoxia; Liver Neoplasms; Micelles; Nitroimidazoles; Polyethylene Glycols; Tumor Microenvironment | 2022 |
Hypoxic targeting and activating TH-302 loaded transcatheter arterial embolization microsphere.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheterization; Cell Hypoxia; Chemoembolization, Therapeutic; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Liver Neoplasms; Microspheres; Nitroimidazoles; Phosphoramide Mustards; Rabbits | 2020 |
Hepatocellular carcinoma targeting agents: conjugates of nitroimidazoles with trimethyl nordihydroguaiaretic acid.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Liver Neoplasms; Masoprocol; Models, Molecular; Molecular Conformation; Nitroimidazoles; Structure-Activity Relationship | 2014 |
Galactose-based Thermosensitive Nanogels for Targeted Drug Delivery of Iodoazomycin Arabinofuranoside (IAZA) for Theranostic Management of Hypoxic Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Galactose; HeLa Cells; Hep G2 Cells; Humans; Liver Neoplasms; MCF-7 Cells; Nanogels; Nitroimidazoles; Polyethylene Glycols; Polyethyleneimine; Radiation-Sensitizing Agents; Temperature; Theranostic Nanomedicine | 2015 |
Imaging hypoxia in orthotopic rat liver tumors with iodine 124-labeled iodoazomycin galactopyranoside PET.
Topics: Animals; Carcinoma, Hepatocellular; Hypoxia; Image Processing, Computer-Assisted; Iodine Radioisotopes; Liver Neoplasms; Monosaccharides; Nitroimidazoles; Positron-Emission Tomography; Rats; Rats, Nude | 2008 |
Cytogenetic effects of the antichagasic benznidazole on human cells in vitro.
Topics: Carcinoma, Hepatocellular; Cell Line; Chromosome Aberrations; Humans; Lymphocytes; Micronucleus Tests; Nitroimidazoles; Sister Chromatid Exchange; Trypanocidal Agents; Tumor Cells, Cultured | 1994 |